Combination of obesity and high-Fat feeding diminishes sensitivity to GLP-1R agonist exendin-4

Diabetes

Volumn 62, Issue 7, 2013, Pages 2410-2415

  Duca, Frank A ^a,b   Sakar, Yassine ^a   Covasa, Mihai ^a,c,d  

^a UMR1319 MICALIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d STEFAN CEL MARE UNIVERSITY OF SUCEAVA   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; MESSENGER RNA; ANTIDIABETIC AGENT; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; PEPTIDE; VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DRUG SENSITIVITY; ENTEROENDOCRINE CELL; FAT INTAKE; FOOD INTAKE; ILEUM; IMMUNOFLUORESCENCE; INTESTINE EPITHELIUM; L CELL; MALE; NODOSE GANGLION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SENSORY NERVE; ANIMAL; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; EATING; GENETICS; INTESTINE MUCOSA; LIPID DIET; METABOLISM;

ADIPOSITY; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; DOWN-REGULATION; EATING; HYPOGLYCEMIC AGENTS; ILEUM; INTESTINAL MUCOSA; MALE; NODOSE GANGLION; OBESITY; PEPTIDES; RATS; RECEPTORS, GLUCAGON; VENOMS;

EID: 84883706833     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1204     Document Type: Article

References (25)

1. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011;378:815-825
2. Bouchard C, Pérusse L. Genetics of obesity. Annu Rev Nutr 1993;13:337- 354
3. Levin BE. Developmental gene x environment interactions affecting systems regulating energy homeostasis and obesity. Front Neuroendocrinol 2010;31:270-283
4. Farley C, Cook JA, Spar BD, Austin TM, Kowalski TJ. Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obes Res 2003;11: 845-851
5. Duca FA, Swartz TD, Sakar Y, Covasa M. Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors. Int J Obes (Lond) 1 May 2012. Available at http://www. nature.com/ijo/journal/vaop/ncurrent/full/ijo201245a.html. Accessed 1 July 2012
6. Greenberg D, McCaffery J, Potack JZ, Bray GA, York DA. Differential satiating effects of fats in the small intestine of obesity-resistant and obesityprone rats. Physiol Behav 1999;66:621-626
7. Duca FA, Covasa M. Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity. Br J Nutr 2012;108:778-793
8. Williams DL, Baskin DG, Schwartz MW. Evidence that intestinal glucagonlike peptide-1 plays a physiological role in satiety. Endocrinology 2009;150: 1680-1687
9. Näslund E, Hellström PM. Glucagon-like peptide-1 in the pathogenesis of obesity. Drug News Perspect 1998;11:92-97
10. Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc 2010;110:571-584
11. Williams DL, Hyvarinen N, Lilly N, et al. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation. Physiol Behav 2011;103:557-564
12. Little TJ, Feltrin KL, Horowitz M, et al. Dose-related effects of lauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2005;289:R1090-R1098
13. Hayes MR, De Jonghe BC, Kanoski SE. Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol Behav 2010;100:503-510
14. Daly DM, Park SJ, Valinsky WC, Beyak MJ. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol 2011;589:2857-2870
15. Paulino G, Barbier de la Serre C, Knotts TA, et al. Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats. Am J Physiol Endocrinol Metab 2009;296:E898-E903
16. Vahl TP, Tauchi M, Durler TS, et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007; 148:4965-4973
17. Williams DL, Baskin DG, Schwartz MW. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 2006; 55:3387-3393
18. de Lartigue G, Barbier de la Serre C, Espero E, Lee J, Raybould HE. Dietinduced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab 2011;301:E187-E195
19. de Lartigue G, Barbier de la Serre C, Espero E, Lee J, Raybould HE. Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats. PLoS ONE 2012;7:e32967
20. Zhao S, Kanoski SE, Yan J, Grill HJ, Hayes MR. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner. Int J Obes (Lond) 2012;36:1522-1528
21. Abu-Hamdah R, Rabiee A, Meneilly GS, Shannon RP, Andersen DK, Elahi D. Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides. J Clin Endocrinol Metab 2009;94:1843-1852
22. Kastin AJ, Akerstrom V. Entry of exendin-4 into brain is rapid but may be limited at high doses. Int J Obes Relat Metab Disord 2003;27:313-318
23. Hayes MR, Kanoski SE, Alhadeff AL, Grill HJ. Comparative effects of the longacting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats. Obesity (Silver Spring) 2011;19:1342-1349
24. Reidelberger RD, Haver AC, Apenteng BA, Anders KL, Steenson SM. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats. Obesity (Silver Spring) 2011;19: 121-12
25. Carr RD, Larsen MO, Jelic K, et al. Secretion and dipeptidyl peptidase- 4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. J Clin Endocrinol Metab 2010;95:872-878